Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen A Flanagan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecular Endocrinology (Baltimore, Md.)|September 20, 2008
A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibitionColin D White, Marla Coetsee, Kevin Morgan, et al.
Molecular Endocrinology (Baltimore, Md.)|September 16, 2006
Conserved amino acid residues that are important for ligand binding in the type I gonadotropin-releasing hormone (GnRH) receptor are required for high potency of GnRH II at the type II GnRH receptorSipho Mamputha, Zhi-Liang Lu, Roger W Roeske, et al.
Endocrine Reviews|April 15, 2004
Gonadotropin-releasing hormone receptorsRobert P Millar, Zhi-Liang Lu, Adam J Pawson, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonistThomas R Ott, Brigitte E Troskie, Roger W Roeske, et al.
Physiological Reports|October 29, 2021
Inflammation-induced left ventricular fibrosis is partially mediated by tumor necrosis factor-αAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
BMC Cardiovascular Disorders|December 10, 2022
Increased protein phosphatase 5 expression in inflammation-induced left ventricular dysfunction in ratsAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
Journal of Cardiovascular Pharmacology|April 20, 2023
Tumor Necrosis Factor-α Mediates Inflammation-induced Early-Stage Left Ventricular Systolic DysfunctionAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
Endocrinology|June 19, 2004
Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for beta-arrestin-independent internalizationKatharina Ronacher, Nosisa Matsiliza, Nonhlanhla Nkwanyana, et al.
Molecular and Cellular Endocrinology|January 14, 2015
Histidine(7.36(305)) in the conserved peptide receptor activation domain of the gonadotropin releasing hormone receptor couples peptide binding and receptor activationNkateko M I Mayevu, Han Choe, Ruben Abagyan, et al.
AIDS Research and Human Retroviruses|November 21, 2008
High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptorBernhard J Fromme, Marla Coetsee, Pauline Van Der Watt, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Endocrinology (Baltimore, Md.)|September 20, 2008
A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibitionColin D White, Marla Coetsee, Kevin Morgan, et al.
Molecular Endocrinology (Baltimore, Md.)|September 16, 2006
Conserved amino acid residues that are important for ligand binding in the type I gonadotropin-releasing hormone (GnRH) receptor are required for high potency of GnRH II at the type II GnRH receptorSipho Mamputha, Zhi-Liang Lu, Roger W Roeske, et al.
Endocrine Reviews|April 15, 2004
Gonadotropin-releasing hormone receptorsRobert P Millar, Zhi-Liang Lu, Adam J Pawson, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonistThomas R Ott, Brigitte E Troskie, Roger W Roeske, et al.
Physiological Reports|October 29, 2021
Inflammation-induced left ventricular fibrosis is partially mediated by tumor necrosis factor-αAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
BMC Cardiovascular Disorders|December 10, 2022
Increased protein phosphatase 5 expression in inflammation-induced left ventricular dysfunction in ratsAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
Journal of Cardiovascular Pharmacology|April 20, 2023
Tumor Necrosis Factor-α Mediates Inflammation-induced Early-Stage Left Ventricular Systolic DysfunctionAshmeetha Manilall, Lebogang Mokotedi, Sulè Gunter, et al.
Endocrinology|June 19, 2004
Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for beta-arrestin-independent internalizationKatharina Ronacher, Nosisa Matsiliza, Nonhlanhla Nkwanyana, et al.
Molecular and Cellular Endocrinology|January 14, 2015
Histidine(7.36(305)) in the conserved peptide receptor activation domain of the gonadotropin releasing hormone receptor couples peptide binding and receptor activationNkateko M I Mayevu, Han Choe, Ruben Abagyan, et al.
AIDS Research and Human Retroviruses|November 21, 2008
High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptorBernhard J Fromme, Marla Coetsee, Pauline Van Der Watt, et al.
Pageof 3